Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
In the latest session, Aspire Biopharma Holdings Inc (NASDAQ: ASBP) closed at $1.88 up 4.14% from its previous closing price of $1.81. In other words, the price has increased by $4.14 from its previous closing price. On the day, 0.59 million shares were traded. ASBP stock price reached its highest trading level at $1.95 during the session, while it also had its lowest trading level at $1.76.
Ratios:
For a deeper understanding of Aspire Biopharma Holdings Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.17 and its Current Ratio is at 0.17.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ASBP now has a Market Capitalization of 7540000 and an Enterprise Value of 11741333. Its current Enterprise Value per Revenue stands at 6049.115.
Stock Price History:
The Beta on a monthly basis for ASBP is 0.84, which has changed by -0.99605316 over the last 52 weeks, in comparison to a change of 0.15024745 over the same period for the S&P500. Over the past 52 weeks, ASBP has reached a high of $632.00, while it has fallen to a 52-week low of $1.65. The 50-Day Moving Average of the stock is -50.76%, while the 200-Day Moving Average is calculated to be -85.09%.
Shares Statistics:
For the past three months, ASBP has traded an average of 1.12M shares per day and 1014346 over the past ten days. A total of 3.46M shares are outstanding, with a floating share count of 3.09M. Insiders hold about 10.84% of the company’s shares, while institutions hold 2.18% stake in the company. Shares short for ASBP as of 1767139200 were 278737 with a Short Ratio of 0.25, compared to 1764288000 on 247039. Therefore, it implies a Short% of Shares Outstanding of 278737 and a Short% of Float of 9.689999.
